Head-to-head · computed 2026-08-11
Sprout Health vs Willow
Sprout Health: Sprout Health sells flat-rate compounded GLP-1s with no membership: $249/month semaglutide (commonly $199 first month; $615 three-month supply, about $205/month) and $299/month tirzepatide (commonly $249 first month), with a published price-lock so the rate holds as the dose climbs — and, unusually for this market, two named partner pharmacies. Willow: Willow sells patient-specific 503A compounded tirzepatide at a flat $399 a month at every dose, telehealth and shipping included, in 33 states as of mid-2026 reporting.
Tirzepatide
| Sprout Health | Willow | |
|---|---|---|
| All-in maintenance | $299/mo | $399/mo |
| Best plan rate | $299/mo | $399/mo |
| 12-month total | $3,588 | $4,788 |
| Status | Reported · 2026-08-11 | Reported · 2026-08-11 |
The arithmetic
On the figures our desk holds, Sprout Health's $299 a month undercuts Willow's $399 by $100 a month at the 10 mg/wk maintenance basis — $1,200 across a year. Sprout Health's figure is reported (captured 2026-08-11) and Willow's is reported (captured 2026-08-11); a status below 'verified' means our independent checkout capture is still pending, so treat the gap as the best current evidence rather than settled fact.
Sprout Health's tirzepatide ladder runs $299 a month billed monthly. Willow's runs $399 a month billed monthly. On the twelve-month basis Sprout Health's $3,588 beats Willow's $4,788 by $1,200 — with the winner's figure resting on twelve months at the month-to-month rate with no commitment, a structural difference that matters if you might stop early.
Sprout Health promotional terms: First month commonly $249.
Semaglutide
Only Sprout Health offers semaglutide ($249 a month billed monthly, and $205 a month on a three-month plan); Willow does not, so there is no contest to score.
Where the structures genuinely differ
On verifiability, Sprout Health names its dispensing pharmacy — which means the fifteen-minute license-and-records check is possible — while Willow's pharmacy is not disclosed on record, the single structural fact this desk weighs heaviest after the FDA's 2026 letters cited exactly that practice.
Structure, side by side
Sprout Health
- MembershipNone
- Dose policyDose-flat with a published price-lock guarantee: the enrolled rate does not increase as the dose escalates
- CommitmentMonth-to-month; 3-month semaglutide supply available
- CancellationPer provider terms
- PharmacyFoothills Pharmacy and Promise Pharmacy (named partners)
Willow
- MembershipNone
- Dose policyDose-flat per captured reporting: flat $399 at every dose
- CommitmentMonthly
- CancellationPer published terms; confirm at checkout
- PharmacyPatient-specific 503A compounding (pharmacy unnamed on captured materials)
What our desk is watching on each
Sprout Health: Resolution on record: our July 16 homepage read ('starting-at entry-dose prices; funnel personalizes') is superseded — five independent 2026 sources converge on flat $249/$299 pricing with an explicit dose price-lock, identifying the homepage 'starting at' as first-month promo framing rather than dose tiering. LegitScript-certified; MD Integrations clinician network; Sprout Health Partners LLC, Encinitas, CA. Cautions that survive the upgrade: a consistent slow-customer-service complaint pattern across review sources, an NAD+ add-on on the menu (see the verification masterclass's add-on cautions), oral compounded tirzepatide tablets offered (less outcome data than injectables), and no labs or telehealth visit required before treatment — fast is not the same as thorough.
Willow: Reported from a June 15, 2026 comparison table (MenoMellow) — our own capture pending; the flat-at-every-dose structure and 33-state footprint both carry that single-source status until independently confirmed. Pharmacy unnamed on captured materials.
Questions people ask
Is Sprout Health or Willow cheaper in 2026?
The tirzepatide and semaglutide verdict blocks above give the computed answer at the maintenance basis, with the verification status of each figure; the short version is that whichever program's all-in monthly number is lower on this page is cheaper on the evidence we hold today, and both rows carry capture dates so you can judge freshness.
What does Sprout Health vs Willow miss that checkout will show?
Taxes, state availability, current promotions, and any dose surcharge introduced after our capture date. Screenshot the order summary before paying — that capture, not any comparison page, is your contract.
Why do you compare at the maintenance dose instead of the starting dose?
Because starter pricing lasts one or two months and maintenance pricing lasts the rest of the year; comparing starts against maintenances is the single most common way GLP-1 comparisons mislead.
What do Sprout Health and Willow cost over a full year of tirzepatide?
On the plans our database holds, a year of tirzepatide runs $3,588 at Sprout Health and $4,788 at Willow — computed from each program's best published twelve-month route, with promotional figures labeled in the sections above and every number carrying its capture date.
Does a promotion affect this comparison?
Yes — at least one program on this page (Sprout Health) is running promotional pricing with its standard rate card stored alongside it. The verdict uses the price a buyer pays today, labeled as promotional; the analysis block prints the reversion figure, because a comparison won on a sale that ends is a comparison that expires.
Both records live in the normalized database; re-run the math yourself from the downloads. Full record pages: Sprout Health · Willow. Official sites: Sprout Health ↗ · Willow ↗. Nothing here is medical advice.